OBJECTIVES: We investigated whether patients with rheumatic and degenerative heart valve disease (HVD) differed with regard to plasma and tissue oxidative stress index (OSI). STUDY DESIGN: The study included 56 patients who underwent valve replacement due to rheumatic (n=32; 15 males; mean age 47+/-10 years) and degenerative (n=24; 13 males; mean age 55+/-12 years) HVD. Plasma and tissue total oxidative status (TOS) and total antioxidative capacity (TAC) levels were measured and OSI was calculated. RESULTS: Patients with degenerative HVD had significantly higher age, increased interventricular septum thickness, and higher frequency of aortic stenosis, whereas the incidence of mitral stenosis was higher in patients with rheumatic HVD (p<0.05). Plasma oxidative characteristics did not differ between the two HVD groups (p>0.05). Tissue TAC was significantly lower in patients with rheumatic HVD (p=0.027), whereas tissue TOS and OSI were similar between the two HVD groups (p>0.05). In bivariate analysis, plasma OSI did not show any correlation with clinical, laboratory, and echocardiographic variables (p>0.05). CONCLUSION: Our data show that plasma and tissue OSI levels are similar in patients with rheumatic and degenerative HVD.
OBJECTIVES: We investigated whether patients with rheumatic and degenerative heart valve disease (HVD) differed with regard to plasma and tissue oxidative stress index (OSI). STUDY DESIGN: The study included 56 patients who underwent valve replacement due to rheumatic (n=32; 15 males; mean age 47+/-10 years) and degenerative (n=24; 13 males; mean age 55+/-12 years) HVD. Plasma and tissue total oxidative status (TOS) and total antioxidative capacity (TAC) levels were measured and OSI was calculated. RESULTS:Patients with degenerative HVD had significantly higher age, increased interventricular septum thickness, and higher frequency of aortic stenosis, whereas the incidence of mitral stenosis was higher in patients with rheumatic HVD (p<0.05). Plasma oxidative characteristics did not differ between the two HVD groups (p>0.05). Tissue TAC was significantly lower in patients with rheumatic HVD (p=0.027), whereas tissue TOS and OSI were similar between the two HVD groups (p>0.05). In bivariate analysis, plasma OSI did not show any correlation with clinical, laboratory, and echocardiographic variables (p>0.05). CONCLUSION: Our data show that plasma and tissue OSI levels are similar in patients with rheumatic and degenerative HVD.
Authors: Aziza Ahmed Hassan; Dina Foad Ghoneim; Amr Abdelraheem El-Dib; Salwa Abdelkawi Ahmed; Ahmed Medhat Abdel-Salam Journal: J Lasers Med Sci Date: 2013
Authors: Maha Sabry Abd Eldaiem; Salwa Abdelkawi Ahmed; Aziza Abdelmonem Elsaeid; Aziza Ahmed Hassan; Dina Fouad Ghoneim; Ahlam Mohammed Ibrahim Journal: J Lasers Med Sci Date: 2021-10-19
Authors: Nihal Tümer; Hale Z Toklu; Judy M Muller-Delp; Sehkar Oktay; Payal Ghosh; Kevin Strang; Michael D Delp; Philip J Scarpace Journal: Physiol Rep Date: 2014-06-06
Authors: Umit Mentese; Orhan Veli Dogan; Ibrahim Turan; Sefer Usta; Emre Dogan; Seda Oztas Mentese; Selim Demir; Tanil Ozer; Ahmet Cagri Aykan; Ahmet Alver Journal: ScientificWorldJournal Date: 2014-08-18